The AHA and the National Independent Laboratory Association today flagged for the National Association of Insurance Commissioners deeply concerning actions by UnitedHealthcare to implement a “misleading” new benefit plan design that will limit access to needed laboratory services. “UHC’s Designated Diagnostic Provider (DDP) program, while couched in the terms of efficiency and quality, effectively creates a tiered benefit design under which patients would be unable to access services provided by in-network hospital and independent laboratories,” the groups wrote. “Under this benefit design, UHC would effectively eliminate coverage for diagnostic tests at all independent and hospital laboratories, including those within its network, unless the facilities agree to participate in the DDP program.” AHA previously asked that the federal government disallow UHC from implementing this program in federally regulated products. 

Related News Articles

Headline
AHA on July 27 sent a letter to the Centers for Medicare & Medicaid Services in response to the proposed rules updating certain rules governing health…
Headline
Sens. Patrick Leahy, D-Vt., and Steve Daines, R-Mont., who cosponsored legislation that repealed the McCarran-Ferguson antitrust exemption for commercial…
Headline
Today, UnitedHealth Group announced a jaw-dropping $6 billion in earnings in a single quarter, but not enough has been said about a big contributor to these…
Blog
Today UnitedHealth Group announced a jaw-dropping $6 billion in earnings in a single quarter. But not enough has been said about a big contributor to these…
Headline
Over 1.5 million people selected a 2021 health plan through the federally facilitated marketplace between Feb. 15 and June 30 during the special…
Headline
The Centers for Medicare & Medicaid Services last week issued a final methodology and data sources necessary to determine federal payment amounts to be…